TSK LABORATORY EUROPE B.V. Gemullehoekenweg CD, Oisterwijk The Netherlands. +31 (0)

Transcription

1

2 TSK LABORATORY EUROPE B.V. Gemullehoekenweg CD, Oisterwijk The Netherlands +31 (0) Needle Innovations brochure All rights reserved. Copyright 2016 by TSK Laboratory Europe B.V. 2

3 CONTENT TSK LABORATORY LOW DEAD SPACE NEEDLE THE INViSIBLE NEEDLE BPA FREE NEEDLE STERiGLIDE CANNULA 3DOSE UNIT DOSE INJECTOR page 04 page 06 page 07 page 08 page 10 page 11 3

4 TSK LABORATORY INNOVATIVE SPECIALITY NEEDLES TSK Laboratory is a familyowned company based in Tochigi, Japan. Established in 1973 it is now comprised of three factories that specialize in the production of high quality needles for the medical, dental, opthalmology and aesthetic markets. All three factories are built with the flexibility to manufacture in small to mid-size production runs, and interchangeable between manual, 4

5 semi-manual and fully automated production lines. All production facilities are ISO certified and have acquired the highest level of inspection and auditing standards by major global pharmaceutical companies, medical companies and government authorities. TSK Laboratory Europe B.V. is located in the Netherlands and manages all sales, marketing and distribution activities for the EMEA region. 5

6 NEEDLE INNOVATIONS LOW DEAD SPACE NEEDLE EXCESSIVE SPACE IN HUB REDUCED NEAR TO ZERO The LOW DEAD SPACE NEEDLE hub is designed to reduce the effective space left behind in the needle hub close to zero. This newly designed LDS hub results in savings of up to 0.08ml which leads to significant cost savings on high cost drugs. Dead Space Regular Hub Dead Space LDS Hub Patent pending NL

7 THE INViSIBLE NEEDLE NEEDLE DIAMETER 14% THINNER THAN 33G THE INViSIBLE NEEDLE is the first needle of its kind and the thinnest needle available to date. Technology advancements have made it possible to make this needle 33% thinner than a 30G needle (used with insulin syringes) and 14% thinner than the TSK 33G needle. This extremely small diameter of THE INViSIBLE NEEDLE results in a near painless experience for patients and greatly reduces the risk for hematomas. Diameter THE INViSIBLE NEEDLE Diameter 30G Regular PRE needle Patent pending NL

8 NEEDLE INNOVATIONS BPA FREE NEEDLE NO BPA, BADGE OR TiO 2 The BPA FREE NEEDLE is made only from safe components, free from bisphenol-a, BAGDE and titanium dioxide. While thinking towards the future and committing to optimal patient safety, TSK s research on new materials and new production techniques have made it possible to introduce the first true BPA Free Needle. This needle is manufactured without compromising on TSK s high quality specifications and sets a new safety standard in the industry. 8 Patent pending EP

9 TSK LABORATORY INTRODUCES THE FIRST BPA FREE NEEDLE The common use of epoxy in the manufacturing of hypodermic needles contains BPA or BADGE. The potential adverse effects have been reported as a result from the release of these uncured epoxy resin particles, and there continues to be uncertainties concerning the risks for patients and medical personnel. The health risks associated with excessive adhesive particles and plastic particles entering the blood stream is judged to be very low during normal use, but it can reach unacceptable levels in extreme situations (i.e. pediatric intensive care units). Another area that is being investigated is whether the use of titanium dioxide (TiO 2 ) is actually needed as a coloring agent. It is unknown what the consequences are for the safety of patients as information on this is lacking in literature and little is known about possible exposure via hypodermic needles. Needle manufacturers, notified bodies and competent authorities are responsible for continuously improving safety and reducing risk for public health. But the ISO 7864 standard for hypodermic injection needles does not impose on any limits in regards to the amount of glue in hypodermic needles, nor has there been any regulation around BPA. TSK Laboratory, one of the leading hypodermic needle manufacturers wanted to be proactive. New production techniques that use only safe components for the production of the BPA FREE NEEDLE, free from Bisphenol A, BAGDE and titanium dioxide have been designed. 9

10 NEEDLE INNOVATIONS STERiGLIDE CANNULA DOME SHAPED TIP FOR 50% BETTER GLIDING The dome shaped tip of the STERiGLIDE creates less resistance than a tip from a traditional cannula. This reduces the force needed and the risk of bruising. Since the introduction of TSK s award-winning STERiGLIDE to the aesthetic market, it has outperformed any other cannula available and remains to lead the market as the golden standard. STERIGLIDE Cannula Traditional Cannula Patent US

11 INJECTOR INNOVATIONS 3DOSE UNIT DOSE INJECTOR 1 CLICK = 1 UNIT DOSE An accurate, consistent and easy method of injecting 3 different unit doses of up to 0,01ml dose accuracy. With the new 3Dose unit dose injector the amount of drugs is always consistent, and the adjustable clicker system allows easy and precise dose injections for Unit indicator 3DOSE pre-set injection volumes. Clicker system 3DOSE Patent pending NL

12 TSK Laboratory Europe B.V. Gemullehoekenweg CD, Oisterwijk - The Netherlands Phone: +31 (0) europe@tsklab.com Web: Instagram: /TSKLaboratory Facebook: /TSKLaboratory Twitter: /TSKLaboratory